Based on our findings in cellular models of TDP-43 proteinopathy, we proposed that 1) there are additional KPNB1 interaction domains present in TDP-43 and 2) additional factors missing in in vitro fibrillization studies but present in cellular TDP-43 aggregates can facilitate this process. This evidence concerns the gene TARDBP and proteostasis deficiencies.